| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/12/2013 | CN1668305B Microbicidal pyrimidine or triazine for preventing sexual HIV transmission |
| 06/12/2013 | CN1525857B Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives |
| 06/12/2013 | CN1461310B ANtibodies that bind human interleukin-18 and methods of making and using |
| 06/12/2013 | CN103154246A Compositions and methods for treating leukemia |
| 06/12/2013 | CN103154245A Antisense nucleic acid |
| 06/12/2013 | CN103154004A Process for preparing compound having HIV integrase inhibitory activity |
| 06/12/2013 | CN103154003A Free crystal of tricyclic pyrazolopyrimidine derivative |
| 06/12/2013 | CN103154000A Buprenorphine analogs |
| 06/12/2013 | CN103153999A Novel compound acting as a cannabinoid receptor-1 inhibitor |
| 06/12/2013 | CN103153997A Quinazoline derivatives |
| 06/12/2013 | CN103153996A Quinoline and quinoxaline derivatives as kinase inhibitors |
| 06/12/2013 | CN103153995A Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors |
| 06/12/2013 | CN103153994A Bicyclic heteroaryl kinase inhibitors and methods of use |
| 06/12/2013 | CN103153993A Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 06/12/2013 | CN103153990A Novel pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof |
| 06/12/2013 | CN103153989A Cathepsin s inhibitor compounds |
| 06/12/2013 | CN103153986A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 06/12/2013 | CN103153984A Inhibitors of bruton's tyrosine kinase |
| 06/12/2013 | CN103153983A Crystalline (r) - (e) -2- (4- (2- (5- (1- (3, 5 -dichloropyridin-4 -yl) ethoxy) - 1H - indazol - 3 - yl) vinyl) -1 H- pyrazol- 1 -yl) ethanol and its use as FGFR inhibitor |
| 06/12/2013 | CN103153982A 4-(1H-Indol-3-yl) -pyrimidines as ALK inhibitors |
| 06/12/2013 | CN103153981A New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl] -phenyl} - cyclohexyl) -acetic acid |
| 06/12/2013 | CN103153980A Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents |
| 06/12/2013 | CN103153978A Compounds and methods for the treatment or prevention of flaviviridae viral infections |
| 06/12/2013 | CN103153977A Organic amine salt of aminobenzoic acid derivative, and method for producing same |
| 06/12/2013 | CN103153975A Novel anphthoquinones for disease therapies? |
| 06/12/2013 | CN103153973A Dihydrobenzoxathiazepine derivatives, preparation thereof, pharmaceutical compositions and use as AMPA receptor modulators |
| 06/12/2013 | CN103153971A Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 06/12/2013 | CN103153970A Oxazole And Thiazole Compounds As Ksp Inhibitors |
| 06/12/2013 | CN103153968A Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 06/12/2013 | CN103153965A Quinoxaline derivates |
| 06/12/2013 | CN103153963A Cyclopropane compound |
| 06/12/2013 | CN103153959A 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators |
| 06/12/2013 | CN103153957A N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| 06/12/2013 | CN103153955A Pyridine compounds and the uses thereof |
| 06/12/2013 | CN103153954A N-acylsulfonamide apoptosis promoters |
| 06/12/2013 | CN103153951A Pyrrolidinones as MetAP-2 inhibitors |
| 06/12/2013 | CN103153950A Serotonin reuptake inhibitors |
| 06/12/2013 | CN103153946A Peripherally restricted FAAH inhibitors |
| 06/12/2013 | CN103153944A Method for producing crystalline 5-aminosalicylic acid |
| 06/12/2013 | CN103153344A Methods, compositions, and kits for the treatment of matrix mineralization disorders |
| 06/12/2013 | CN103153343A Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
| 06/12/2013 | CN103153335A Small-molecule-targeted protein degradation |
| 06/12/2013 | CN103153316A Combined drug delivery methods and apparatus |
| 06/12/2013 | CN103153315A Method for treating cystic fibrosis with inhaled denufosol |
| 06/12/2013 | CN103153314A 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 06/12/2013 | CN103153313A Compositions for treating heartworm infestation |
| 06/12/2013 | CN103153312A Piroxicam for prophylactically and therapeutically treating herpes infections |
| 06/12/2013 | CN103153311A The use of inhibitors of bruton's tyrosine kinase (btk) |
| 06/12/2013 | CN103153310A Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals |
| 06/12/2013 | CN103153309A Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridone |
| 06/12/2013 | CN103153308A TRPA1 receptor antagonist |
| 06/12/2013 | CN103153307A Oxazole derivatives useful as modulators of faah |
| 06/12/2013 | CN103153306A Solid dispersion comprising triazole compound |
| 06/12/2013 | CN103153305A Pharmaceutical combinations |
| 06/12/2013 | CN103153304A Compositions for treating helicobacter pylori infection |
| 06/12/2013 | CN103153303A Combination therapy using a ruthenium complex |
| 06/12/2013 | CN103153302A Biomarkers for mdm2 inhibitors for use in treating disease |
| 06/12/2013 | CN103153301A Methods of treatment |
| 06/12/2013 | CN103153300A Heteroaryls and uses thereof |
| 06/12/2013 | CN103153299A Prophylactic and/or therapeutic agent against lymphedema |
| 06/12/2013 | CN103153298A Materials and methods for improving gastrointestinal function |
| 06/12/2013 | CN103153297A Terpenoid analogues and uses thereof for treating neurological conditions |
| 06/12/2013 | CN103153296A Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists |
| 06/12/2013 | CN103153295A Novel use of leflunomide and malononitrilamides |
| 06/12/2013 | CN103153294A Transdermal patch and method for augmenting adhesive strength thereof |
| 06/12/2013 | CN103153293A Supramolecular complexes of polyanionic polymers and spermidine in tissue maintenance and repair |
| 06/12/2013 | CN103153292A Combination anti-cancer therapy |
| 06/12/2013 | CN103153290A Antimicrobial formulations that aid in wound healing |
| 06/12/2013 | CN103153288A Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 06/12/2013 | CN103153287A Pharmaceutical composition of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration therof |
| 06/12/2013 | CN103153286A Pharmaceutical composition and administrations thereof |
| 06/12/2013 | CN103153282A Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 06/12/2013 | CN103153279A Skin compositions and methods of use thereof |
| 06/12/2013 | CN103153245A Methods of treating conditions associated with overactive bladder |
| 06/12/2013 | CN103153064A Methods for inhibiting cell proliferation in EGFR-driven cancers |
| 06/12/2013 | CN103153063A Quinoline derivatives and MELK inhibitors containing the same |
| 06/12/2013 | CN103153062A Heterocyclic compounds and uses thereof |
| 06/12/2013 | CN103153053A Diketones and hydroxyketones as catenin signaling pathway activators |
| 06/12/2013 | CN103153045A Compositions for controlling heartworm infestation |
| 06/12/2013 | CN103145868A Derivate of low molecular weight fucosylated glycosaminoglycan and medical composition and preparation method and application thereof |
| 06/12/2013 | CN103145865A Preparation method and application of stereum hirsutum mycelium polysaccharide |
| 06/12/2013 | CN103145864A Codonopsis pilosula uniform polysaccharide CPPib, preparation and application thereof |
| 06/12/2013 | CN103145863A Method of extracting cynomorium songaricum polysaccharide through enzyme treatment and preparation of cynomorium songaricum polysaccharide antineoplastic agents |
| 06/12/2013 | CN103145844A A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 06/12/2013 | CN103145795A Cycloartane type triterpene compound and application thereof |
| 06/12/2013 | CN103145794A Cimicifuga triterpenoid compound and application thereof |
| 06/12/2013 | CN103145792A Shionone triterpenes as well as pharmaceutical compositions, preparation methods and applications of shionone triterpenes |
| 06/12/2013 | CN103145779A 3,5-dimethyl-8-(3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-oxo) heterochromatic original alkyl-1-one, preparation method and application thereof |
| 06/12/2013 | CN103145776A Gastrodin extraction method, preparation method of gastrodia elata soft capsules and soft capsules obtained by preparation method |
| 06/12/2013 | CN103145774A Anticoagulation pentose and preparation method thereof |
| 06/12/2013 | CN103145773A Crystalline solvates and complexes of (IS) -1, 5-anhydro-L-C- (3- ( (phenyl) methyl) phenyl) -D-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes |
| 06/12/2013 | CN103145762A Divalent-platinum complex containing sterically-hindered aryl group and preparation method and application thereof |
| 06/12/2013 | CN103145759A Alizarin molybdenum complex, preparation method, and application thereof in preventing and treating cancers |
| 06/12/2013 | CN103145741A Bisindole compound and medical composition and preparation method and use thereof |
| 06/12/2013 | CN103145740A Sulfoxide alkaloid compound as well as preparation method and application for same |
| 06/12/2013 | CN103145739A Pyrimido thiazole type compounds with anti-inflammatory effect and application thereof in preparation of anti-inflammatory medicaments |
| 06/12/2013 | CN103145738A Imidazo [2,1-b] thiayole derivatives as SIRTUIN modulating compounds |
| 06/12/2013 | CN103145736A Medicine composite containing cefamandole nafate compound |
| 06/12/2013 | CN103145735A Cefmenoxime hydrochloride compound for injection and pharmaceutical composition thereof |
| 06/12/2013 | CN103145734A Cefuroxime lysine and preparation thereof |